Actions of prolactin on human renal function

RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells.

Journal of bone oncology·2016

Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.

European journal of cancer (Oxford, England : 1990)·2015

Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease.

Journal of gastrointestinal cancer·2014

Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses.

Clinical oncology (Royal College of Radiologists (Great Britain))·2012

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Cancer treatment reviews·2012

Transforming growth-factor-alpha and factor-beta(1) levels in plasma and effusions from patients with cancer or hematologic malignancies.

International journal of oncology·2011

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Fertility Treatment Using Assisted Reproductive Technology During Immune Checkpoint Inhibition: Report of Two Cases.

The oncologist·2026

Reproductive healthcare use before and after infertility diagnosis: a population-based study in South Korea.

BMJ open·2026

Cost-effectiveness of safer conception strategies for HIV-discordant couples in Zimbabwe.

Journal of acquired immune deficiency syndromes (1999)·2026

Late-follicular androgen and estrogen rise associated with clinical pregnancy in IVF/ICSI with granulosa cell studies.

Reproduction & fertility·2026

Innovative treatment approaches for azoospermia: causes, emerging techniques, and future directions.

Molecular biology reports·2026

Effect of patient and partner preconceptional nutraceutical supplementation on the onset of natural pregnancy: a retrospective study.

Revista da Associacao Medica Brasileira (1992)·2026

Related Experiment Videos

Actions of prolactin on human renal function

Related Concept Videos

RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells.

Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.

Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease.

Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses.

Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

Transforming growth-factor-alpha and factor-beta(1) levels in plasma and effusions from patients with cancer or hematologic malignancies.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Fertility Treatment Using Assisted Reproductive Technology During Immune Checkpoint Inhibition: Report of Two Cases.

Reproductive healthcare use before and after infertility diagnosis: a population-based study in South Korea.

Cost-effectiveness of safer conception strategies for HIV-discordant couples in Zimbabwe.

Late-follicular androgen and estrogen rise associated with clinical pregnancy in IVF/ICSI with granulosa cell studies.

Innovative treatment approaches for azoospermia: causes, emerging techniques, and future directions.

Effect of patient and partner preconceptional nutraceutical supplementation on the onset of natural pregnancy: a retrospective study.

Related Experiment Videos

Actions of prolactin on human renal function

Related Concept Videos

Related Articles